I now have comprehensive data from multiple authoritative sources. Here is the full synthesis:
Autonomic Neuropathy & Diagnosis of Small Fiber Neuropathy
Part 1: Autonomic Neuropathy
What It Is
Autonomic neuropathy results from damage to the small unmyelinated (C) and thinly myelinated (Aδ) autonomic fibers that control cardiovascular, gastrointestinal, genitourinary, sudomotor, and pupillomotor function. It commonly occurs in combination with small fiber sensory neuropathy — both affecting the same fiber classes.
Clinical Manifestations by System
| System | Symptoms | Signs |
|---|
| Cardiovascular | Dizziness/fainting on standing, palpitations, supine hypertension | Orthostatic hypotension (↓SBP ≥20 or ↓DBP ≥10 mmHg on standing) without compensatory tachycardia; fixed heart rate; loss of respiratory sinus arrhythmia |
| Gastrointestinal | Early satiety, bloating, nausea/vomiting (gastroparesis), constipation or diarrhea, fecal urgency/incontinence | Reduced salivation, impaired anal tone |
| Genitourinary | Erectile dysfunction (often first manifestation in men), retrograde ejaculation, urinary urgency, incomplete bladder emptying | Atonic bladder on urodynamics, large post-void residual |
| Sudomotor/Skin | Dry feet and hands, absent sweating distally, heat intolerance, compensatory hyperhidrosis proximally | Dry skin, absent pilomotor reaction, pallor |
| Ocular | Dry/gritty eyes, poor dark adaptation | Impaired pupillary light reflex, Horner syndrome (ptosis, miosis) |
| Thermoregulatory | Abnormal temperature regulation, exercise intolerance | Absent distal sweating on TST |
Clinical pearl: In males, erectile dysfunction is typically the earliest symptom of autonomic neuropathy. Orthostatic hypotension without a compensatory rise in heart rate is pathognomonic of efferent sympathetic failure.
Causes of Autonomic Neuropathy
| Category | Examples |
|---|
| Metabolic | Diabetes mellitus (#1 cause), metabolic syndrome, uremia |
| Autoimmune | Sjögren syndrome (#2 after DM), SLE, RA, CIDP, paraneoplastic (anti-Hu, anti-VGCC) |
| Infiltrative | Amyloidosis (especially if profound autonomic + sensory loss — think transthyretin amyloid) |
| Infectious | HIV, Herpes zoster, Lyme disease, syphilis |
| Hereditary | Fabry disease (α-galactosidase deficiency), porphyria |
| Iatrogenic | Drugs (antihypertensives, tricyclics, antipsychotics) |
| Primary | Pure autonomic failure, MSA (central), pandysautonomia |
Autonomic Testing
| Test | What It Assesses | Finding in Autonomic Neuropathy |
|---|
| Orthostatic BP/HR | Sympathetic vasomotor + baroreflex | ↓BP on standing; absent HR rise |
| Valsalva ratio (max:min HR) | Vagal cardiac control | Ratio <1.5 (reduced) |
| Deep breathing (E:I ratio) | Cardiovagal function | Reduced HR variability |
| Tilt-table test | Prolonged orthostatic stress | Delayed orthostatic hypotension |
| Thermoregulatory sweat test (TST) | Global sudomotor map | Distal anhidrosis (peripheral pattern in length-dependent neuropathy) |
| QSART (quantitative sudomotor axon reflex test) | Postganglionic sudomotor axon function | Reduced or absent sweat output distally |
| Sympathetic skin response (SSR) | Sudomotor/emotional sweating | Absent or reduced |
| Bladder urodynamics | Detrusor function | Large post-void residual, atonic bladder |
| Gastric emptying study | Gastroparesis | Delayed emptying with solid meal |
Part 2: Small Fiber Neuropathy (SFN)
Definition
SFN is selective damage to Aδ (thinly myelinated) and C (unmyelinated) fibers, sparing large myelinated Aα/Aβ fibers. This creates a clinical-electrodiagnostic dissociation: severe symptoms + normal standard NCS.
Clinical Presentation
| Feature | Details |
|---|
| Pain quality | Burning, stinging, lancinating, electric shock-like — typically worse at night |
| Location | Feet first (length-dependent); may spread proximally |
| Sensory deficit | Loss of pinprick and temperature sensation in stocking distribution |
| Large fiber function | Preserved: vibration, proprioception, Romberg (until late), coordination |
| Reflexes | Normal (large Aα fibers intact) |
| Autonomic features | Dry feet, absent sweating, skin color changes (livedo, erythromelalgia), trophic changes — autonomic Aδ/C fiber loss |
| Motor function | Normal |
Bedside recognition: Burning pain in feet + normal reflexes + normal vibration + normal NCS = small fiber neuropathy until proven otherwise
Diagnostic Approach
Step 1: Clinical Suspicion
Neuropathic pain + sensory loss (pinprick/temp) + normal neurological examination (reflexes, proprioception, strength) + normal NCS
Step 2: Standard Electrodiagnostics
- NCS: Normal (does not evaluate Aδ/C fibers) — this is a key diagnostic feature, not a negative result
- EMG: Normal
Step 3: Confirmatory Testing
| Test | Method | Interpretation |
|---|
| Skin biopsy (IENFD) ⭐ gold standard | 3 mm punch biopsy, typically at distal leg (10 cm above lateral malleolus); stained with PGP 9.5 antibody (pan-axonal marker) | Reduced intraepidermal nerve fiber density (IENFD) below age/sex-adjusted normative values confirms SFN |
| QSART | Iontophoresis of acetylcholine activates postganglionic sudomotor axons | Reduced sweat volume = postganglionic C fiber loss |
| Thermoregulatory sweat test (TST) | Whole-body heat stimulus; quinizarin powder changes color when sweat is produced | Distal anhidrosis pattern |
| Quantitative sensory testing (QST) | Warm/cool detection thresholds using Peltier device | Elevated warm detection threshold; elevated heat pain threshold |
| Corneal confocal microscopy | Non-invasive imaging of corneal nerve fiber layer | Reduced corneal nerve fiber length/density (correlates with IENFD) |
Etiological Workup for SFN
| Investigation | Targets |
|---|
| Fasting glucose, 2-hr OGTT, HbA1c | Diabetes, prediabetes (impaired glucose tolerance is present in >50% of "idiopathic" SFN) |
| Anti-nuclear antibodies, anti-Ro/La (SSA/SSB) | Sjögren syndrome |
| Serum protein electrophoresis, immunofixation | Monoclonal gammopathy (IgM anti-MAG, POEMS) |
| Paraneoplastic panel (anti-Hu, anti-Yo, anti-CV2) | Occult malignancy |
| Alpha-galactosidase A level | Fabry disease |
| Transthyretin gene mutation | Hereditary amyloidosis |
| Voltage-gated sodium channel sequencing (SCN9A = Nav1.7) | Inherited SFN (gain-of-function mutations) |
| Vitamin B12, B6, methylmalonic acid | Deficiency / B6 toxicity |
| HIV serology, Lyme, hepatitis C | Infectious |
| Heavy metals | Arsenic, thallium toxicity |
SFN vs. Large Fiber Neuropathy: Bedside Comparison
| Feature | Small Fiber Neuropathy | Large Fiber Neuropathy |
|---|
| Pain | Prominent (burning, allodynia) | Less (mainly numbness) |
| Pinprick/temp | Lost | Preserved |
| Vibration/proprioception | Preserved | Lost |
| Reflexes | Normal | Reduced/absent |
| Strength | Normal | May be reduced |
| NCS | Normal | Abnormal |
| Skin biopsy | ↓ IENFD | Usually not needed |
| Romberg | Negative | Positive |
Sources: Bradley & Daroff's Neurology in Clinical Practice; Goldman-Cecil Medicine; Adams & Victor's Principles of Neurology, 12th Ed.